Effects of ghrelin, leptin and melatonin on the levels of reactive oxygen species, antioxidant enzyme activity and viability of the HCT 116 human colorectal carcinoma cell line
- PMID: 25873273
- DOI: 10.3892/mmr.2015.3599
Effects of ghrelin, leptin and melatonin on the levels of reactive oxygen species, antioxidant enzyme activity and viability of the HCT 116 human colorectal carcinoma cell line
Abstract
Obesity is associated with an increased risk of certain types of cancer, including colon cancer. Adipose tissue is an endocrine organ that produces biologically active substances, such as leptin and ghrelin. Recent research has suggested that adipose-derived hormones may be associated with mechanisms linked to tumorigenesis and cancer progression. Furthermore, previous studies have demonstrated that pineal gland-derived melatonin possesses important oncostatic and antioxidant properties. The present study aimed to determine the effects of the adipokines ghrelin and leptin, and the melatonin on intracellular levels of reactive oxygen species (ROS) and the activity of selected antioxidant enzymes, such as superoxide dismutase, catalase (CAT) and glutathione peroxidase. The effects of these compounds were also determined on the viability of HCT 116 human colorectal carcinoma cells in vitro. The pro-oxidant and growth inhibitory effects of melatonin resulted in an accumulation of ROS and decreased antioxidant capacity in melatonin-treated cells. Ghrelin administration alone caused a significant decrease in the levels of ROS, due to an increased activity of CAT in the HCT 116 cells. In addition, the present study observed increased lipid peroxidation following melatonin treatment, and decreased levels of malondialdehyde following ghrelin or leptin treatment. In conclusion, ghrelin, leptin and melatonin have various influences on the antioxidant capacity of HCT 116 cells. Compared with the adipokines, treatment with melatonin increased ROS levels and decreased cellular viability.
Similar articles
-
Viability and oxidative response of human colorectal HCT-116 cancer cells treated with visfatin/eNampt in vitro.J Physiol Pharmacol. 2015 Aug;66(4):557-66. J Physiol Pharmacol. 2015. PMID: 26348080
-
Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism.J Physiol Pharmacol. 2007 Mar;58 Suppl 1:53-64. J Physiol Pharmacol. 2007. PMID: 17443027
-
Melatonin administration differentially affects age-induced alterations in daily rhythms of lipid peroxidation and antioxidant enzymes in male rat liver.Biogerontology. 2012 Oct;13(5):511-24. doi: 10.1007/s10522-012-9396-1. Epub 2012 Sep 9. Biogerontology. 2012. PMID: 22960749
-
Inflammation, oxidative stress, and obesity.Int J Mol Sci. 2011;12(5):3117-32. doi: 10.3390/ijms12053117. Epub 2011 May 13. Int J Mol Sci. 2011. PMID: 21686173 Free PMC article. Review.
-
Regulation of antioxidant enzymes: a significant role for melatonin.J Pineal Res. 2004 Jan;36(1):1-9. doi: 10.1046/j.1600-079x.2003.00092.x. J Pineal Res. 2004. PMID: 14675124 Review.
Cited by
-
Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression.Int J Mol Sci. 2021 Feb 1;22(3):1444. doi: 10.3390/ijms22031444. Int J Mol Sci. 2021. PMID: 33535537 Free PMC article. Review.
-
The role of melatonin in colorectal cancer treatment: a comprehensive review.Ther Adv Med Oncol. 2020 Jul 17;12:1758835920931714. doi: 10.1177/1758835920931714. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32733605 Free PMC article. Review.
-
Melatonin increases 5-flurouracil-mediated apoptosis of colorectal cancer cells through enhancing oxidative stress and downregulating survivin and XIAP.Bioimpacts. 2021;11(4):253-261. doi: 10.34172/bi.2021.36. Epub 2020 Jul 8. Bioimpacts. 2021. PMID: 34631487 Free PMC article.
-
The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial.Clin Transl Oncol. 2019 Jun;21(6):745-752. doi: 10.1007/s12094-018-1977-2. Epub 2018 Nov 12. Clin Transl Oncol. 2019. PMID: 30421178 Clinical Trial.
-
Impact of Andrographolide and Melatonin Combinatorial Drug Therapy on Metastatic Colon Cancer Cells and Organoids.Clin Med Insights Oncol. 2021 Jun 4;15:11795549211012672. doi: 10.1177/11795549211012672. eCollection 2021. Clin Med Insights Oncol. 2021. PMID: 34158803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous